GSK Investigational Site — Alabaster, Alabama

GSK Investigational Site is a clinical research site located in Alabaster, Alabama, United States 35007.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 13 clinical trials.

Therapeutic areas: Epilepsy, Partial, Restless Legs Syndrome, Diabetes Mellitus, Type 2.

Sponsors: GlaxoSmithKline, XenoPort, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 13 clinical trials on record. Their work covers Epilepsy, Partial, Restless Legs Syndrome, Diabetes Mellitus, Type 2.

Is GSK Investigational Site accredited by Crixeo Health?

Yes — GSK Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.